Shots:
- Quebec will follow a similar approach to policies introduced in British Columbia, Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. This will contribute to annual savings that can be reinvested in healthcare and innovative new drugs
- The transition will take place under the supervision of the attending physicians & patients will continue receiving safe & effective treatment
- Sandoz Canada is committed to supporting patients, their HCPs, and the Quebec government throughout the transition period with quality biosimilar medicines, medical teams, physician, and pharmacist advocacy teams, as well as with patient support programs
Click here to read full press release/ article | Ref: Sandoz| Image: Sandoz
The post Sandoz Canada Congratulates the Quebec Government on Implementing a Shift Towards Biosimilars first appeared on PharmaShots.
